Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$185,932,054
+$55,308,160 QoQ
Shares Held
155,017
+9.2% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
1.98%
of 13F equity value
Holder Rank
#271
of 4,605 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 86%
Shared 1%
None 12%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pinnacle Financial Partners, Inc. holds $518,224,933 across 13 Drug Manufacturers - General names. LLY ranks #1 (35.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
155,017 | $185,932,054 | |
| 2 | JNJ |
Johnson & Johnson
|
447,481 | $113,646,747 | |
| 3 | ABBV |
AbbVie Inc.
|
309,302 | $77,832,753 | |
| 4 | MRK |
Merck & Co., Inc.
|
324,931 | $41,753,633 | |
| 5 | AMGN |
Amgen Inc
|
107,659 | $38,985,475 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
298,653 | $17,208,384 | |
| 7 | PFE |
Pfizer Inc
|
697,936 | $16,806,297 | |
| 8 | AZN |
Astrazeneca PLC
|
51,065 | $9,682,943 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $185,932,054 | 155,017 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $130,623,894 | 142,018 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $153,630,893 | 142,955 | Shares | Other | 2026-02-18 | |
| No filing history on record for this holder in this stock. | ||||||